Evidence map›Paper›PMID 33227907›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Absence of

Jessie E Wozniak, Aroon T Chande, Eileen M Burd, Victor I Band, Sarah W Satola, Monica M Farley, Jesse T Jacob, I King Jordan, David S Weiss

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Osteomyelitis.Nature reviews. Disease primers · 2026
    Review
  2. Sequential antibiotic exposure restores antibiotic susceptibility.The Journal of antimicrobial chemotherapy · 2025
    Article
  3. Polymyxin resistance in Enterobacter cloacae complex in Brazil: phenotypic and molecular characterization.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jessie E WozniakEmory Vaccine Center, Atlanta, GA 30317, USA.
Aroon T ChandeInstitute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.ORCID 0000-0001-5260-3135
Eileen M BurdSchool of Medicine, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0002-7055-942X
Victor I BandEmory Vaccine Center, Atlanta, GA 30317, USA.
Sarah W SatolaSchool of Medicine, Emory University, Atlanta, GA 30322, USA.
Monica M FarleySchool of Medicine, Emory University, Atlanta, GA 30322, USA.
Jesse T JacobSchool of Medicine, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0001-9811-6260
I King JordanSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
David S WeissEmory Vaccine Center, Atlanta, GA 30317, USA.
Emory Healthcare · USGeorgia Institute of Technology · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Mechanisms of phenotypic antibiotic resistance in Gram-negative bacteriaR01AI141883 · NIAID · EMORY UNIVERSITY · PI WEISS, DAVID S · 2018 to 2022
$2.2M
Burroughs Wellcome Fund David S. WeissNIAID NIH HHS R01 AI141883NIH HHS AI141883NIH HHS P51 OD011132
6 · The paper itself

Abstract

Colistin is an important last-line antibiotic to treat highly resistant

Indexed as

colistinCREEnterobacter

Identifiers

PMID33227907
PMCPMC7699182
OpenAlexW3105084953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.